Proprietary CDMS platform — from eCRF to statistical analysis.

Explore · 72%

Our French specialist in clinical biometrics & data management — and the cornerstone of the Oxurion platform.

Oxurion/Investors/News/ThromboGenics announces publication in Experimental Eye R…

ThromboGenics announces publication in Experimental Eye Research of preclinical data supporting therapeutic potential of THR-317 in DR

9 Oct 2017General

Oxurion (Euronext Brussels: OXUR) is a Belgian company building a leading European group of clinical research organizations.

OXUR · EURONEXT BRUSSELS€0.0034

0.00%·3 Jun 2026

Oxurion NV
Gaston Geenslaan 1
B-3001 Leuven
Belgium

info@oxurion.com
+32 16 75 13 10